The genetics of lipid storage and human lipodystrophies

Trends in Molecular Medicine

Volumn 21, Issue 7, 2015, Pages 433-438

  Robbins, Ann L ^a   Savage, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ectopic fat; Insulin resistance; Lipid droplet; Lipodystrophy

Indexed keywords

ADIPOPHILIN; CARBOHYDRATE; FATTY ACID; INSULIN; PERILIPIN; TRIACYLGLYCEROL;

ADIPOCYTE; AMINO ACID METABOLISM; AUTOSOMAL DOMINANT INHERITANCE; BODY MASS; CAENORHABDITIS ELEGANS; CALORIC INTAKE; CARDIOMYOPATHY; CONGENITAL GENERALIZED LIPODYSTROPHY; CYTOSOL; ENERGY RESOURCE; FAMILIAL PARTIAL LIPODYSTROPHY; GENETIC VARIABILITY; HUMAN; HUMAN GENETICS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DEGRADATION; LIPID METABOLISM; LIPID STORAGE; LIPODYSTROPHY; LIPOGENESIS; LIPOLYSIS; LOSS OF FUNCTION MUTATION; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT AVAILABILITY; OBESITY; REVIEW; SACCHAROMYCES CEREVISIAE; SKELETAL MUSCLE; SURFACE AREA; TARGET ORGAN; WHITE ADIPOCYTE; ADIPOSE TISSUE; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; HUMANS; INSULIN RESISTANCE; LIPODYSTROPHY;

EID: 84933676570     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.04.004     Document Type: Review

References (73)

1. Berg J.M., et al. Biochemistry 2002, W.H. Freeman and Company.
2. Murphy D.J. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 2001, 40:325-438.
3. Klug L., Daum G. Yeast lipid metabolism at a glance. FEMS Yeast Res. 2014, 14:369-388.
4. Dahlqvist A., et al. Phospholipid: diacylglycerol acyltransferase: an enzyme that catalyzes the acyl-CoA-independent formation of triacylglycerol in yeast and plants. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6487-6492.
5. Oelkers P., et al. The DGA1 gene determines a second triglyceride synthetic pathway in yeast. J. Biol. Chem. 2002, 277:8877-8881.
6. Oelkers P., et al. A lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterification in yeast. J. Biol. Chem. 2000, 275:15609-15612.
7. Sandager L., et al. Storage lipid synthesis is non-essential in yeast. J. Biol. Chem. 2002, 277:6478-6482.
8. Arrese E.L., Soulages J.L. Insect fat body: energy, metabolism, and regulation. Annu. Rev. Entomol. 2010, 55:207-225.
9. Gesta S., et al. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131:242-256.
10. Pond C.M. An evolutionary and functional view of mammalian adipose-tissue. Proc. Nutr. Soc. 1992, 51:367-377.
11. Yang L., et al. The proteomics of lipid droplets: structure, dynamics, and functions of the organelle conserved from bacteria to humans. J. Lipid Res. 2012, 53:1245-1253.
12. Brasaemle D.L. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 2007, 48:2547-2559.
13. Patel S., et al. Perilipins 2 and 3 lack a carboxy-terminal domain present in perilipin 1 involved in sequestering ABHD5 and suppressing basal lipolysis. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:9163-9168.
14. Gronke S., et al. Control of fat storage by a Drosophila PAT domain protein. Curr. Biol. 2003, 13:603-606.
15. Xu L., et al. CIDE proteins and lipid metabolism. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1094-1098.
16. Puri V., Czech M.P. Lipid droplets: FSP27 knockout enhances their sizzle. J. Clin. Invest. 2008, 118:2693-2696.
17. Rubio-Cabezas O., et al Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 2009, 1:280-287.
18. Reue K. A thematic review series: lipid droplet storage and metabolism: from yeast to man. J. Lipid Res. 2011, 52:1865-1868.
19. Kuehnlein R.P. Lipid droplet synthesis and metabolism: from yeast to man lipid droplet-based storage fat metabolism in Drosophila. J. Lipid Res. 2012, 53:1430-1436.
20. Mak H.Y. Lipid droplets as fat storage organelles in Caenorhabditis elegans. J. Lipid Res. 2012, 53:28-33.
21. Kaneko K., et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review. Neuromuscul. Disord. 2014, 24:634-641.
22. Liang W.C., Nishino I. State of the art in muscle lipid diseases. Acta Myol. 2010, 29:351-356.
23. Schweiger M., et al. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E289-E296.
24. Albert J.S., et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N. Engl. J. Med. 2014, 370:2307-2315.
25. Savage D.B., et al. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 2007, 87:507-520.
26. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
27. Garg A., Agarwal A.K. Lipodystrophies: disorders of adipose tissue biology. Biochim. Biophys. Acta 2009, 1791:507-513.
28. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J. Clin, Endocrinol. Metab. 2011, 96:3313-3325.
29. Cao H., Hegele R. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 2000, 9:109-112.
30. Agarwal A., Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 2002, 87:408-411.
31. George S., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004, 304:1325-1328.
32. Gandotra S., et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 2011, 364:740-748.
33. Barroso I., et al. Dominant negative mutations in human PPAR gamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999, 402:880-883.
34. Weedon M.N., et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat. Genet. 2013, 45:947-950.
35. Novelli G., et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 2002, 71:426-431.
36. Agarwal A., et al. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 2003, 12:1995-2001.
37. Huang-Doran I., et al. Lipodystrophy: metabolic insights from a rare disorder. J. Endocrinol. 2010, 207:245-255.
38. Agarwal A., et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 2002, 31:21-23.
39. Magre J., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 2001, 28:365-370.
40. Kim C., et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 2008, 93:1129-1134.
41. Hayashi Y., et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest. 2009, 119:2623-2633.
42. Savage D.B., et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 2003, 52:910-917.
43. Rosen E.D., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
44. Payne V.A., et al. The human lipodystrophy gene BSCL2/Seipin may be essential for normal adipocyte differentiation. Diabetes 2008, 57:2055-2060.
45. Boguslavsky R.L., et al. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 2006, 15:653-663.
46. Meaburn K.J., et al. Primary laminopathy fibroblasts display altered genome organization and apoptosis. Aging Cell 2007, 6:139-153.
47. Bergo M.O., et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13049-13054.
48. Pol A., et al. Dynamic and regulated association of caveolin with lipid bodies: Modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell 2004, 15:99-110.
49. Pilch P.F., Liu L.B. Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes. Trends Endocrinol. Metab. 2011, 22:318-324.
50. Liu L.B., et al. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab. 2008, 8:310-317.
51. Nishino N., et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J. Clin. Invest. 2008, 118:2808-2821.
52. Perry R.J., et al. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014, 510:84-91.
53. Muoio D.M., Newgard C.B. Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:193-205.
54. Muoio D.M. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell 2014, 159:1253-1262.
55. Chao L., et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 2000, 106:1221-1228.
56. Rodeheffer M.S., et al. Identification of white adipocyte progenitor cells in vivo. Cell 2008, 135:240-249.
57. Petersen K.F., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 2002, 109:1345-1350.
58. Shimomura I., et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999, 401:73-76.
59. Oral E.A., et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 2002, 346:570-578.
60. Robbins D.C., et al. Effect of diet on thermogenesis in acquired lipodystrophy. Metabolism 1979, 28:908-916.
61. Kozusko K., et al. Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy. Diabetes 2015, 64:299-310.
62. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106:171-176.
63. Virtue S., Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol. 2008, 6:1819-1823.
64. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat. Genet. 2000, 26:13.
65. Scott R.A., et al. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity. Diabetes 2014, 63:4378-4387.
66. Yaghootkar H., et al. Genetic evidence for a normal-weight 'metabolically obese' phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes 2014, 63:4369-4377.
67. Yamauchi T., et al. Mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulin resistance. J. Biol. Chem. 2001, 276:41245-41254.
68. Kim J-Y., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
69. Cinti S., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46:2347-2355.
70. McNelis J.C., Olefsky J.M. Macrophages, immunity, and metabolic disease. Immunity 2014, 41:36-48.
71. Strissel K.J., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56:2910-2918.
72. Toh S.Y., et al. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of Fsp27 deficient Mice. PLoS ONE 2008, 3:e2890.
73. Zhou L., et al. Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice. Nat. Commun. 2015, 6:5949.